Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

E-wallet giant GCash is unlikely to cash in on the opportunity to go public this year. GCash president and CEO Martha Sazon ...